Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
05/2012
05/23/2012CN101642469B Application of umbilical cord mesenchymal stem cells (MSCs) in the acute myocardial infarction cell transplantation therapy
05/23/2012CN101633947B New method for preparing sunflower seed meal proteolytic peptide and application of sunflower seed meal proteolytic peptide
05/23/2012CN101601469B Health care medicinal liquor and preparation method thereof
05/23/2012CN101590163B Medicament for treating dementia and preparation method thereof
05/23/2012CN101554438B Traditional Chinese medicine for curing hemorrhoids
05/23/2012CN101544631B Novel pyrazole 5-lipoxygenase small molecule inhibitors, preparation method, pharmaceutical composition and application thereof
05/23/2012CN101530620B Triphosadenine intercalated houghite membrane and preparation method thereof
05/23/2012CN101522670B Pyridin-3-yl derivatives as immunomodulating agents
05/23/2012CN101511789B 5,6-bisaryl-2-pyridine-carboxamide derivatives, preparation and application thereof in therapeutics as urotensin II receptor antagonists
05/23/2012CN101503369B Method for preparing vanillyl acidamide compounds by interfacial reaction
05/23/2012CN101496792B Punailuoer or delayed-release preparation of salt thereof and preparation method thereof
05/23/2012CN101480402B Cycloartenyl ferulate composition and method for preparing the same
05/23/2012CN101475564B Novel preparation of losartan potassium
05/23/2012CN101433567B Clinical novel use of soft capsule for removing thromboembolism
05/23/2012CN101401875B Proprietary Chinese medicine for reducing blood pressure
05/23/2012CN101395152B Sigma receptor compounds
05/23/2012CN101381356B Preparation method of simvastatin
05/23/2012CN101380391B Traditional Chinese medicine external application paste for treating angiitis
05/23/2012CN101292962B Felodipine controlled release formulation and preparation method thereof
05/23/2012CN101234169B Application of Chinese medicine composition in preparing medicament for adjusting cardiac muscle cell potassium ion channel
05/23/2012CN101209312B Digitalis extract and preparation thereof
05/23/2012CN101199848B Drug compound for Ca channel retarder/diuretic/ folate coupling and function
05/23/2012CN101137639B Flavonoid compounds and uses thereof
05/23/2012CN101103013B 1-thio-D-glucitol derivatives
05/23/2012CN101066311B Total jasminoidin extract and its preparation process
05/23/2012CN101011413B Use of hydrogen sulfide and its donor sodium hydrosulfide in the production of medicaments
05/22/2012US8183361 Oligonucleotide-containing pharmacological compositions and their use
05/22/2012US8183295 Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic
05/22/2012US8183273 Bicyclic compound, production and use thereof
05/22/2012US8183234 Tricyclic guanidine derivatives as sodium-proton exchange inhibitors
05/22/2012US8183232 Therapeutic agent for hemorrhoidal disease
05/22/2012US8183226 Myocardial perfusion imaging method
05/22/2012US8183213 Combination therapy comprising glucose reabsorption inhibitors and retinoid-X receptor modulators
05/22/2012US8183206 Particularly 3-methyl-1-phenyl-2-pyrazolin-5-one; thrombolytic agent, an anticoagulant and/or a platelet aggregation inhibitory agent such as a thromboxane synthetase inhibitor; for treating and/or preventing ischemic diseases which are safe and have few side effects
05/22/2012US8183203 Methods for treating pulmonary hypertension and compositions comprising vasoactive intestinal peptide
05/22/2012CA2632949C Use of dha, epa or dha-derived epa for treating a pathology associated with cellular oxidative damage
05/22/2012CA2571649C Pharmaceutical compositions containing a selective and specific sinus node if current inhibitor and a calcium inhibitor, and their use
05/22/2012CA2395165C Treatment of hibernating myocardium and diabetic cardiomyopathy with a glp-1 peptide
05/18/2012WO2012065133A1 Immunomodulatory methods and systems for treatment and/or prevention of aneurysms
05/18/2012WO2012065106A2 Compounds and related methods for manipulating parp-1-dependent cell death
05/18/2012WO2012065059A2 Treatment of atherosclerosis with bmp-alk3 antagonists
05/18/2012WO2012064943A2 Metalloenzyme inhibitor compounds
05/18/2012WO2012064910A1 Piperidinone carboxamide azaindane cgrp receptor antagonists
05/18/2012WO2012064807A1 Crystalline forms of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid
05/18/2012WO2012064559A1 Sgc stimulators
05/18/2012WO2012063955A1 Therapeutic agent for arteriosclerosis or arteriosclerotic disorders and diagnostic agent for arteriosclerosis or arteriosclerotic disorders
05/18/2012WO2012063896A1 Novel pyrazole amide derivative
05/18/2012WO2012063820A1 Suppressor for increase in blood glucose level
05/18/2012WO2012063553A1 Agent for reducing risk of disease onset resulting from non-dipper type intra-day blood pressure fluctuation
05/18/2012WO2012062676A1 Lisuride, terguride and derivatives thereof for use in the prophylaxis and/or treatment of fibrotic changes
05/18/2012WO2012062157A1 Pyrano[3,2-d]thiazol derivatives and uses thereof as selective glycosidase inhibitors
05/18/2012WO2012061972A1 Selective glycosidase inhibitors and uses thereof
05/18/2012WO2012061971A1 Selective glycosidase inhibitors and uses thereof
05/18/2012WO2012027277A3 Compositions for reducing the deleterious effects of stress and aging
05/18/2012WO2012014085A3 Uses of cimiracemate a and related compounds for treating inflammation and modulating immune responses
05/18/2012WO2011028737A8 Bisphosphonate compositions and methods for treating heart failure
05/18/2012WO2010151095A8 Novel acetylsalicylic acid salts
05/18/2012CA2834882A1 Lisuride, terguride and derivatives thereof for use in the prophylaxis and/or treatment of fibrotic changes
05/18/2012CA2817691A1 Metalloenzyme inhibitor compounds
05/18/2012CA2817538A1 Immunomodulatory methods and systems for treatment and/or prevention of aneurysms
05/18/2012CA2817319A1 Sgc stimulators
05/18/2012CA2817100A1 Piperidinone carboxamide azaindane cgrp receptor antagonists
05/18/2012CA2812598A1 Crystalline forms of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid
05/17/2012US20120122988 4-(phenoxyalkyl)thio)-phenoxyacetic acids and analogs
05/17/2012US20120122977 Substituted amino bisphenyl pentanoic acid derivatives as NEP inhibitors
05/17/2012US20120122972 Novel eicosanoid derivatives
05/17/2012US20120122971 New process for preparing hydroxylamines and medicaments
05/17/2012US20120122960 Organic Compositions to Treat Beta-ENaC-Related Diseases
05/17/2012US20120122959 Targeting MicroRNAs for Metabolic Disorders
05/17/2012US20120122955 Use of lna apob antisense oligomers for the treatment of acute coronary syndromes
05/17/2012US20120122948 3-alkyl-5-fluoroindole derivatives as myeloperoxidase inhibitors
05/17/2012US20120122944 Tetrahydronaphthalene derivatives
05/17/2012US20120122940 Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas
05/17/2012US20120122930 1H-Benzimidazole-5-Carboxamides As Anti-Inflammatory Agents
05/17/2012US20120122925 Perhexiline for use in the treatment of hypertrophic cardiomyopathy (hcm)
05/17/2012US20120122924 Nampt inhibitors
05/17/2012US20120122917 Method For Treatment Of HIV And Diseases Of Immune Dysregulation
05/17/2012US20120122909 Spiro-oxindole compounds and their uses as therapeutic agents
05/17/2012US20120122907 Novel Pyrazole Derivatives and their use as Positive Allosteric Modulators of Metabotropic Glutamate Receptors
05/17/2012US20120122906 Novel sulfonamide derivative and pharmaceutical product containing same
05/17/2012US20120122894 Inhibitors of bruton's tyrosine kinase
05/17/2012US20120122889 Small molecule inhibitors of necroptosis
05/17/2012US20120122883 New salts
05/17/2012US20120122879 Compounds useful as protein kinase inhibitors
05/17/2012US20120122873 Amino derivatives of dihydro-1,3,5-triazine used in the treatment of ischemia and/or reperfusion related diseases
05/17/2012US20120122870 Treatment Of Ischemia-Reperfusion Injury
05/17/2012US20120122863 Quinazolinedione Chymase Inhibitors
05/17/2012US20120122858 Lactam compounds and their use as pharmaceuticals
05/17/2012US20120122857 Heterobicyclic carboxamides as inhibitors for kinases
05/17/2012US20120122855 Benzoxazines, benzothiazines, and related compounds having nos inhibitory activity
05/17/2012US20120122854 Carbocyclic Fused Cyclic Amines
05/17/2012US20120122850 Biphenyl compounds useful as muscarinic receptor antagonists
05/17/2012US20120122842 Nampt and rock inhibitors
05/17/2012US20120122839 Novel pyrrolidin-2-ones
05/17/2012US20120122837 Inhibitors of fatty acid binding protein
05/17/2012US20120122835 Poly (ADP-Ribose) Polymerase (PARP) Inhibitors
05/17/2012US20120122827 Novel derivatives of cholest-4-en-3-one oxime, pharmaceutical compositions containing them and preparation method
05/17/2012US20120122824 Reduction of Side Effects From Aromatase Inhibitors Used for Treating Breast Cancer
05/17/2012US20120122820 Prodrugs and the use thereof
05/17/2012US20120122789 Methods of Reducing Myocardial Injury Following Myocardial Infarction
1 ... 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 ... 1595